Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

PROSHARES TRUST (ZBIO) Equity Ratio: 2023-2025

Historic Equity Ratio for Zenas BioPharma (ZBIO) over the last 1 years, with Sep 2025 value amounting to 0.61.

  • Zenas BioPharma's Equity Ratio fell 31.53% to 0.61 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.61, marking a year-over-year decrease of 31.53%. This contributed to the annual value of 0.84 for FY2024, which is 125.51% up from last year.
  • Zenas BioPharma's Equity Ratio amounted to 0.61 in Q3 2025, which was down 25.39% from 0.82 recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Equity Ratio registered a high of 0.89 during Q3 2024, and its lowest value of -3.31 during Q4 2023.
  • For the 3-year period, Zenas BioPharma's Equity Ratio averaged around 0.12, with its median value being 0.83 (2025).
  • In the last 5 years, Zenas BioPharma's Equity Ratio skyrocketed by 125.51% in 2024 and then tumbled by 31.53% in 2025.
  • Quarterly analysis of 3 years shows Zenas BioPharma's Equity Ratio stood at -3.31 in 2023, then skyrocketed by 125.51% to 0.84 in 2024, then slumped by 31.53% to 0.61 in 2025.
  • Its last three reported values are 0.61 in Q3 2025, 0.82 for Q2 2025, and 0.85 during Q1 2025.